FDA limits acetaminophen: Risk of death with tigecycline

Journal of the American Academy of Physician Assistants

Volumn 25, Issue 9, 2012, Pages 16-

  DeDea, Larissa ^a  

^a Northern Arizona Healthcare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867063950     PISSN: 15471896     EISSN: 08937400     Source Type: Journal    
DOI: 10.1097/01720610-201209000-00002     Document Type: Note

References (2)

1. FDA drug safety communication: Prescription acetaminophen products to be limited to 325mg per dosage unit; boxed warning will highlight potential for severe liver failure. http://www.fda.gov/Drugs/DrugSafety/ucm239821.htm. Released January 13, 2011. Accessed August 9, 2012.
2. Prasad P, Sun J, Danner RL, Natanson C. Excess deaths associated with tigecycline after approval based on noninferiority trials. Clin Infect Dis. 2012;54(12):1699-1709.